Samrat Pharmachem [SAMRATPH] vs Deepak Nitrite [DEEPAKNTR] Detailed Stock Comparison

Samrat Pharmachem Ltd.

BSE
Loading...

Deepak Nitrite Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem Ltd. wins in 8 metrics, Deepak Nitrite Ltd. wins in 11 metrics, with 0 ties. Deepak Nitrite Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Samrat Pharmachem Ltd. Deepak Nitrite Ltd. Better
P/E Ratio (TTM) 39.68 43.19 Samrat Pharmachem Ltd.
Price-to-Book Ratio 0.98 4.18 Samrat Pharmachem Ltd.
Debt-to-Equity Ratio 15.49 22.41 Samrat Pharmachem Ltd.
PEG Ratio -0.34 23.89 Deepak Nitrite Ltd.
EV/EBITDA -93.75 26.49 Deepak Nitrite Ltd.
Profit Margin (TTM) -0.58% 6.71% Deepak Nitrite Ltd.
Operating Margin (TTM) -1.33% 7.76% Deepak Nitrite Ltd.
EBITDA Margin (TTM) N/A 7.76% N/A
Return on Equity 9.91% 12.85% Deepak Nitrite Ltd.
Return on Assets (TTM) 5.85% 9.03% Deepak Nitrite Ltd.
Free Cash Flow (TTM) $-105.99M $-5.12B Samrat Pharmachem Ltd.
Dividend Yield 0.29% 0.41% Deepak Nitrite Ltd.
1-Year Return -37.34% -17.03% Deepak Nitrite Ltd.
Price-to-Sales Ratio (TTM) 0.24 2.90 Samrat Pharmachem Ltd.
Enterprise Value $597.84M $245.50B Deepak Nitrite Ltd.
EV/Revenue Ratio 0.21 3.09 Samrat Pharmachem Ltd.
Gross Profit Margin (TTM) 2.59% 27.84% Deepak Nitrite Ltd.
Revenue per Share (TTM) $936 $583 Samrat Pharmachem Ltd.
Earnings per Share (Diluted) $-5.42 $39.14 Deepak Nitrite Ltd.
Beta (Stock Volatility) -0.35 0.17 Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. vs Deepak Nitrite Ltd. Stock Performance Analysis

Loading Price Chart...

SAMRATPH
DEEPAKNTR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem Ltd.-0.22%-8.21%-2.79%2.34%-20.83%-8.96%
Deepak Nitrite Ltd.0.74%-0.93%-3.05%14.11%11.57%-0.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem Ltd.-37.34%-40.14%-1.85%833.96%1,047.00%2,384.03%
Deepak Nitrite Ltd.-17.03%-19.39%-2.87%1,957.49%8,856.34%9,344.13%

Performance & Financial Health Analysis: Samrat Pharmachem Ltd. vs Deepak Nitrite Ltd.

MetricSAMRATPHDEEPAKNTR
Market Information
Market Cap i₹676.34M₹230.55B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,760339,159
90 Day Avg. Volume i2,391241,701
Last Close₹207.35₹1,698.90
52 Week Range₹190.00 - ₹389.00₹1,280.00 - ₹2,033.30
% from 52W High-46.70%-16.45%
All-Time High₹1,250.00 (Sep 19, 2022)₹3,169.00 (Jul 29, 2024)
% from All-Time High-83.41%-46.39%
Growth Metrics
Quarterly Revenue Growth0.00%0.04%
Quarterly Earnings Growth0.00%0.02%
Financial Health
Profit Margin (TTM) i-0.01%0.07%
Operating Margin (TTM) i-0.01%0.08%
Return on Equity (TTM) i0.10%0.13%
Debt to Equity (MRQ) i15.4922.41
Cash & Liquidity
Book Value per Share (MRQ)₹228.64₹404.66
Cash per Share (MRQ)₹62.79₹24.86
Operating Cash Flow (TTM) i₹1.26M₹7.00B
Levered Free Cash Flow (TTM) i₹71.12M₹6.97B
Dividends
Last 12-Month Dividend Yield i0.29%0.41%
Last 12-Month Dividend i₹1.00₹7.50

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem Ltd. vs Deepak Nitrite Ltd.

MetricSAMRATPH (Apr 24, 2026)DEEPAKNTR (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i39.6843.19
Forward P/E iN/A32.69
PEG Ratio i-0.3423.89
Price to Sales (TTM) i0.242.90
Price to Book (MRQ) i0.984.18
Market Capitalization
Market Capitalization i₹676.34M₹230.55B
Enterprise Value i₹597.84M₹245.50B
Enterprise Value Metrics
Enterprise to Revenue i0.213.09
Enterprise to EBITDA i-93.7526.49
Risk & Other Metrics
Beta i-0.350.17
Book Value per Share (MRQ) i₹228.64₹404.66

Financial Statements Comparison: Samrat Pharmachem Ltd. vs Deepak Nitrite Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAMRATPH (2025)DEEPAKNTR (2025)
Revenue/Sales i2.86B80.91B
Cost of Goods Sold i2.71B62.89B
COGS % of Revenue i94.7%77.7%
Gross Profit i152.75M18.03B
Gross Margin i5.3%22.3%
Research & Development i0N/A
Operating Income (EBIT) i97.54M9.08B
Operating Margin i3.4%11.2%
EBITDA i107.17M11.51B
EBITDA Margin i3.7%14.2%
Pre-Tax Income i98.86M9.53B
Pre-Tax Income % of Revenue i3.5%11.8%
Income Tax i27.74M2.55B
Income Tax % of Revenue i1.0%3.2%
Net Income (Profit) i71.12M6.97B
Profit Margin i2.5%8.6%

Balance Sheet & Liquidity Metrics

MetricSAMRATPH (2025)DEEPAKNTR (2025)
Cash & Equivalents i483,0001.79B
Total Current Assets i1.03B32.97B
Total Current Assets % of Revenue i36.2%40.7%
Total Current Liabilities i495.83M9.23B
Total Current Liabilities % of Revenue i17.3%11.4%
Long-Term Debt i011.14B
Long-Term Debt % of Revenue i0.0%13.8%
Total Shareholders Equity i718.00M54.25B
Retained Earnings i687.11M48.27B
Retained Earnings % of Revenue i24.0%59.7%
Property, Plant & Equipment i024.00B

Cash Flow Statement Comparison

MetricSAMRATPH (2025)DEEPAKNTR (2025)
Operating Cash Flow i1.26M7.00B
Operating Cash Flow % of Revenue i0.0%8.6%
Capital Expenditures i-5.07M-11.05B
Free Cash Flow i-105.99M-5.12B
FCF Margin i-3.7%-6.3%
Debt Repayment iN/A0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHDEEPAKNTR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.09M136.39M
Float Shares i1.19M67.94M
% Held by Insiders i59.26%49.84%
% Held by Institutions i0.00%24.71%
% Held by Public i40.74%25.45%

Dividend Analysis & Yield Comparison: Samrat Pharmachem Ltd. vs Deepak Nitrite Ltd.

MetricSAMRATPHDEEPAKNTR
Last 12-Month Dividend i₹1.00₹7.50
Last 12-Month Dividend Yield i0.29%0.41%
3-Year Avg Annual Dividend i₹1.67₹7.50
3-Year Avg Dividend Yield i0.17%0.34%
3-Year Total Dividends i₹5.00₹22.50
Ex-Dividend DateSep 19, 2024Aug 04, 2025